Symptoms and Systemic Drug Reactions in Persons Receiving Weekly Rifapentine Plus Isoniazid (3HP) Treatment for Latent Tuberculosis Infection.
Saved in:
| Title: | Symptoms and Systemic Drug Reactions in Persons Receiving Weekly Rifapentine Plus Isoniazid (3HP) Treatment for Latent Tuberculosis Infection. |
|---|---|
| Authors: | Sadowski C; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.; Clinical Research Branch, Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee, USA., Belknap R; Denver Metro Tuberculosis Program, Denver Public Health, Denver, Colorado, USA., Holland DP; Department of Medicine, Division of Infectious Diseases, Emory University, Atlanta, Georgia, USA., Moro RN; CDC Foundation, Research Collaboration, Atlanta, Georgia, USA.; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), US Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Chen MP; Immunization Services Division, National Center for Immunization and Respiratory Diseases (NCIRD), US Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Wright A; Division of Infectious Diseases, Vanderbilt University Medical Centers, Nashville, Tennessee, USA., Millet JP; Epidemiology Service, Public Health Agency of Barcelona, Barcelona, Spain.; CIBER de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.; Foundation of Tuberculosis Research Unit of Barcelona, Barcelona, Spain., Caylà JA; Foundation of Tuberculosis Research Unit of Barcelona, Barcelona, Spain., Scott NA; Clinical Research Branch, Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), US Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Borisov A; Clinical Research Branch, Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), US Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Gandhi NR; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA. |
| Source: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Jun 16; Vol. 76 (12), pp. 2090-2097. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1537-6591 |
|---|---|
| DOI: | 10.1093/cid/ciad083 |
